SEC Form 4 · accession 0001179110-17-005133
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jaime Contreras
Officer — Senior Vice President
Period of report
Mar 21, 2017
Accepted (ET)
Mar 24, 2017 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Mar 21, 2017 | G | 394 | $0.00 | D | 45,339 | D | |
| Common shares without par valueF1 | Mar 21, 2017 | G | 394 | $0.00 | A | 64,297 | I | Jaime Contreras Marvan 2006 Living Trust |
| Common shares without par valueF2 | holding | — | — | — | 21 | I | Profit Sharing Trust | |
| Common shares without par valueF3 | holding | — | — | — | 2,426 | I | By Spouse | |
| Common shares without par valueF4 | holding | — | — | — | 12,081 | I | Living Trust (by spouse) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
- F2Balance in the Abbott Laboratories Stock Retirement Trust as of March 22, 2017.
- F3The reporting person disclaims beneficial ownership of all securities held by his spouse.
- F4Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.